The Cannabis Report Model Portfolio June 26, 2020
30 Junho 2020 - 9:01AM
InvestorsHub NewsWire
PUBLISHED: Jun 30 2020 10:29
I would like to wish all of our American subscribers a
happy and safe Fourth of July and I also hope all of our Canadian
subscribers have a happy and safe Canada Day.
Highlights: all currency references in
this report are Canadian dollars except where noted otherwise
- The model portfolio had a reasonable week easing -2.1% compared
with -1.8% for the Let’s Toke Business Marijuana Composite Index
and a drop of -6.3% in the MJ Canada Index as adjusted.
- The star of the portfolio last week
was Sunniva (OTCMKTS: SNNVF) that closed at
$0.17 per share for a gain of +6.9%. This is a great example of
something that confuses many investors, namely, how does a stock
rise when the company has just reported receiving a Cease Trading
Order? There are many ways to try to explain it but here is one of
my favourites. The stock market not a thermometer; it is a
barometer. In other words, a thermometer tells you what the
temperature is at present. A barometer gives you an indication of
what the weather will be in the future. So SNNVF rising tells you
what investors believe Sunniva’s future looks like and not how it
is today.
- IM Cannabis Corp. (CSE:
IMCC) maintained its position as the largest
holding in the portfolio. IMCC actually had a very positive week
moving up to an all-time high of $1.34 per share before settling
back to close at $1.18 per share. This was still a healthy +4.4%
advance in a week where most of the indexes were lower. This week
IMCC announced that in a peer reviewed study, two of the IM
Cannabis branded strains recorded an improvement in those with
migraine headaches in 60% of cases.
To read more from Ted Ohashi including
an interview with the Chief Executive Officer
of Khiron Life
Sciences - CLICK
HERE
Khiron Life Sciences (TSXV:KHRN)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Khiron Life Sciences (TSXV:KHRN)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
Notícias em tempo-real sobre Khiron Life Sciences Corp da TSX Venture Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Khiron Life Sciences Corp